Literature DB >> 25556253

Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.

Xin Wang1, Kathleen A Shutt2, Jeni T Vuong1, Amanda Cohn1, Jessica MacNeil1, Susanna Schmink1, Brian Plikaytis1, Nancy E Messonnier1, Lee H Harrison2, Thomas A Clark1, Leonard W Mayer1.   

Abstract

BACKGROUND: Meningococcal conjugate vaccines against serogroups A, C, W, and Y (MenACWY) are recommended for routine use in adolescents aged 11-18 years. The impact of these vaccines on the meningococcal population structure in the United States have yet to be evaluated.
METHODS: Meningococcal isolates recovered during 2006-2010 (ie, after introduction of MenACWY) collected through Active Bacterial Core surveillance (ABCs) were characterized; serogroup distribution and molecular features of these isolates were compared to previously published data on ABCs isolates recovered from 2000 to 2005 (ie, before introduction of MenACWY). P values were generated using χ(2) statistics and exact methods.
RESULTS: There was a significant change (P < .05) in serogroup distribution among all age groups between the 2 periods. A small proportion of isolates showed evidence of capsular switching in both periods. Between the 2 periods, significant changes were observed in the distribution of porin A, ferric enterobactin transport, and strain genotypes among vaccine and nonvaccine serogroups.
CONCLUSIONS: The population structure of US meningococcal isolates is dynamic; some changes occurred over time, but the basic structure remained. Vaccine-induced serogroup replacement was not observed, although a small proportion of isolates had undergone capsule switching, possibly driven by non-vaccine-mediated selection. Changes in the distribution of molecular features are likely due to horizontal gene transfer and changes in serogroup distribution. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  meningococcal disease; molecular epidemiology; vaccine impact

Mesh:

Substances:

Year:  2015        PMID: 25556253     DOI: 10.1093/infdis/jiu842

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

2.  Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.

Authors:  Raffaella Rossi; Peter T Beernink; Serena Giuntini; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2015-09-30

Review 3.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

4.  Population structure of invasive Neisseria meningitidis in the United States, 2011-15.

Authors:  Caelin C Potts; Sandeep J Joseph; How-Yi Chang; Alexander Chen; Jeni Vuong; Fang Hu; Laurel T Jenkins; Susanna Schmink; Amy Blain; Jessica R MacNeil; Lee H Harrison; Xin Wang
Journal:  J Infect       Date:  2018-06-30       Impact factor: 6.072

Review 5.  Routinely vaccinating adolescents against meningococcus: targeting transmission & disease.

Authors:  Volker Vetter; Roger Baxter; Gülhan Denizer; Marco A P Sáfadi; Sven-Arne Silfverdal; Andrew Vyse; Ray Borrow
Journal:  Expert Rev Vaccines       Date:  2016-03-04       Impact factor: 5.217

6.  Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia.

Authors:  Shakeel Mowlaboccus; Timothy T Perkins; Helen Smith; Theo Sloots; Sarah Tozer; Lydia-Jessica Prempeh; Chin Yen Tay; Fanny Peters; David Speers; Anthony D Keil; Charlene M Kahler
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

7.  Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles.

Authors:  Adam C Retchless; Cécilia B Kretz; How-Yi Chang; Jose A Bazan; A Jeanine Abrams; Abigail Norris Turner; Laurel T Jenkins; David L Trees; Yih-Ling Tzeng; David S Stephens; Jessica R MacNeil; Xin Wang
Journal:  BMC Genomics       Date:  2018-03-02       Impact factor: 3.969

8.  Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA.

Authors:  Li Hao; Matthew T G Holden; Xin Wang; Lubomira Andrew; Sabine Wellnitz; Fang Hu; Melissa Whaley; Scott Sammons; Kristen Knipe; Mike Frace; Lucy A McNamara; Paul Liberator; Annaliesa S Anderson
Journal:  Microb Genom       Date:  2018-04-04

Review 9.  A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control.

Authors:  Yih-Ling Tzeng; David S Stephens
Journal:  Microorganisms       Date:  2021-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.